Literature DB >> 22977663

High RSF-1 expression correlates with poor prognosis in patients with gastric adenocarcinoma.

Ben-Shun Hu1, Hai-Feng Yu, Gao Zhao, Tian-Zhou Zha.   

Abstract

AIM: To investigate the expression and prognostic significance of RSF-1 in gastric adenocarcinoma.
METHODS: RSF-1 expression was analyzed using immunohistochemical staining on tissue samples from a consecutive series of 287 gastric adenocarcinoma patients who underwent tumor resections between 2003 and 2006.The relationship between RSF-1 expression, clinicopathological factors, and patient survival was investigated.
RESULTS: Immunohistochemical staining indicated that RSF-1 is highly expressed in 52.6% of gastric adenocarcinomas. RSF-1 expression levels were closely associated with tumor size, histological differentiation, tumor stage, and lymph node involvement. Kaplan-Meier survival analysis showed that high RSF-1 expression exhibited a significant correlation with poor prognosis for gastric adenocarcinoma patients. Multivariate analysis revealed that RSF-1 expression is an independent prognostic parameter for the overall survival rate of gastric adenocarcinoma patients.
CONCLUSION: Our data suggest that RSF-1 plays an important role in gastric adenocarcinoma progression and that high RSF-1 expression predicts an unfavorable prognosis in gastric adenocarcinoma patients.

Entities:  

Keywords:  RSF-1; diagnosis; gastric adenocarcinoma; prognosis; survival

Mesh:

Substances:

Year:  2012        PMID: 22977663      PMCID: PMC3438760     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  18 in total

Review 1.  ATP-dependent chromatin-remodeling complexes.

Authors:  M Vignali; A H Hassan; K E Neely; J L Workman
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

2.  HBXAP, a novel PHD-finger protein, possesses transcription repression activity.

Authors:  Meir Shamay; Orr Barak; Yosef Shaul
Journal:  Genomics       Date:  2002-04       Impact factor: 5.736

3.  Overexpression of a chromatin remodeling factor, RSF-1/HBXAP, correlates with aggressive oral squamous cell carcinoma.

Authors:  Fu-Min Fang; Chien-Feng Li; Hsuan-Ying Huang; Ming-Tsong Lai; Chih-Mei Chen; I-Wen Chiu; Tian-Li Wang; Fuu-Jen Tsai; Ie-Ming Shih; Jim Jinn-Chyuan Sheu
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

Review 4.  Non-Hodgkin lymphoma: an update.

Authors:  Bryan T Hennessy; Emer O Hanrahan; Peter A Daly
Journal:  Lancet Oncol       Date:  2004-06       Impact factor: 41.316

5.  Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial.

Authors:  K Kelly; J Crowley; P A Bunn; C A Presant; P K Grevstad; C M Moinpour; S D Ramsey; A J Wozniak; G R Weiss; D F Moore; V K Israel; R B Livingston; D R Gandara
Journal:  J Clin Oncol       Date:  2001-07-01       Impact factor: 44.544

6.  Hepatitis B virus pX interacts with HBXAP, a PHD finger protein to coactivate transcription.

Authors:  Meir Shamay; Orr Barak; Gilad Doitsh; Israel Ben-Dor; Yosef Shaul
Journal:  J Biol Chem       Date:  2002-01-11       Impact factor: 5.157

7.  Cloning and mapping of SMARCA5 encoding hSNF2H, a novel human homologue of Drosophila ISWI.

Authors:  T Aihara; Y Miyoshi; K Koyama; M Suzuki; E Takahashi; M Monden; Y Nakamura
Journal:  Cytogenet Cell Genet       Date:  1998

8.  Functional analysis of the subunits of the chromatin assembly factor RSF.

Authors:  Alejandra Loyola; Jing-Yi Huang; Gary LeRoy; Sherrie Hu; Yuh-Hwa Wang; Robert J Donnelly; William S Lane; Sheng-Chung Lee; Danny Reinberg
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

9.  Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study.

Authors:  R S Brown; R L Wahl
Journal:  Cancer       Date:  1993-11-15       Impact factor: 6.860

Review 10.  Gastric cancer.

Authors:  Peter Hohenberger; Stephan Gretschel
Journal:  Lancet       Date:  2003-07-26       Impact factor: 79.321

View more
  9 in total

1.  Prognostic value of rsf-1/hbxap in human solid tumors: a meta-analysis of cohort studies.

Authors:  Jiayuan Wu; Liren Hu; Fenping Wu; Taiping He
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Ataxin-3 expression correlates with the clinicopathologic features of gastric cancer.

Authors:  Li-Xia Zeng; Yong Tang; Yun Ma
Journal:  Int J Clin Exp Med       Date:  2014-04-15

3.  Integration of genomic data enables selective discovery of breast cancer drivers.

Authors:  Félix Sanchez-Garcia; Patricia Villagrasa; Junji Matsui; Dylan Kotliar; Verónica Castro; Uri-David Akavia; Bo-Juen Chen; Laura Saucedo-Cuevas; Ruth Rodriguez Barrueco; David Llobet-Navas; Jose M Silva; Dana Pe'er
Journal:  Cell       Date:  2014-11-26       Impact factor: 41.582

4.  Overexpression of IL-9 receptor in diffuse large B-cell lymphoma.

Authors:  Xiao Lv; Lili Feng; Xiaosheng Fang; Yujie Jiang; Xin Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-04-15

5.  RSF1 regulates the proliferation and paclitaxel resistance via modulating NF-κB signaling pathway in nasopharyngeal carcinoma.

Authors:  Yong Liu; Guo Li; Chao Liu; Yaoyun Tang; Shuai Zhang
Journal:  J Cancer       Date:  2017-02-09       Impact factor: 4.207

6.  Effects of RSF-1 on proliferation and apoptosis of breast cancer cells.

Authors:  Yuhui Liu; Junda Gai; Lin Fu; Xiuwei Zhang; Enhua Wang; Qingchang Li
Journal:  Oncol Lett       Date:  2018-07-18       Impact factor: 2.967

7.  Rsf‑1 regulates malignant melanoma cell viability and chemoresistance via NF‑κB/Bcl‑2 signaling.

Authors:  Jiani He; Lin Fu; Qingchang Li
Journal:  Mol Med Rep       Date:  2019-08-23       Impact factor: 2.952

8.  RSF-1 siRNA Enhances Tumor Radiosensitivity in Cervical Cancer via Enhanced DNA Damage, Cell Cycle Redistribution, and Promotion of Apoptosis.

Authors:  Jing Tian; Enqi Kong; Xiangyu Wang; Zhaoguang Xie; Cherry Yin-Yi Chang; Jim Jinn-Chyuan Sheu; Quan Hao; Li Sun
Journal:  Onco Targets Ther       Date:  2020-04-09       Impact factor: 4.147

9.  RSF-1 overexpression determines cancer progression and drug resistance in cervical cancer.

Authors:  Xiangyu Wang; Jim Jinn-Chyuan Sheu; Ming-Tsung Lai; Cherry Yin-Yi Chang; Xiugui Sheng; Ling Wei; Yongsheng Gao; Xingwu Wang; Naifu Liu; Wenli Xie; Chih-Mei Chen; Wendy Y Ding; Li Sun
Journal:  Biomedicine (Taipei)       Date:  2018-02-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.